3 hours Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.comMarketBeat
StockNews.com initiated coverage on shares of Revance Therapeutics in a research report on Thursday. They set a “hold” rating on the stock.
XStockNews.com initiated coverage on shares of Revance Therapeutics in a research report on Thursday. They set a “hold” rating on the stock.
X